Business • Health Care

EU secures 30,000 doses of Covid-19 drug

Despite uncertainties in the effectiveness of treatment with Remdesivir, the European Commission has secured from US-based Gilead 30,000 doses on a 63 million contract.
Remdesivir is the first drug to be approved in the European Union for the treatment of Covid-19.

Software therapist 👨🏽‍🔧 Human experience optimizer 🦸🏽 Guardian of the galaxy
Card reviewed by: @ericof